Search Our Site

News filed in:

"Latest News"

AbbVie is accused of paying kickbacks, using a stealthy network of nurses to promote Humira

Column Title In a wide-ranging scheme, AbbVie (ABBV) used a combination of old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira treatment, according to a lawsuit filed on Tuesday by the California insurance commissioner. Over a five-year period, the drug maker offered physicians a familiar menu of... Read More »

Read More →

Column Title In a wide-ranging scheme, AbbVie (ABBV) used a combination of old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira treatment, according to a lawsuit filed on Tuesday by the California insurance commissioner. Over a five-year period, the drug maker offered physicians a familiar menu of… Read More »

[...]

Read More

Study finds multiple sclerosis drug slows brain shrinkage

  An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Robert J. Fox, M.D., Cleveland Clinic, OH. Results from a clinical trial of more than 250 participants with progressive multiple sclerosis(MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study... Read More »

Read More →

  An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Robert J. Fox, M.D., Cleveland Clinic, OH. Results from a clinical trial of more than 250 participants with progressive multiple sclerosis(MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study… Read More »

[...]

Read More

Google DeepMind’s AI can detect over 50 sight-threatening eye conditions

Chris Jackson/Getty Images A focus on artificial intelligence could lead to fewer people losing their sight. Tech industry insiders regularly herald AI as the solution to all of our problems, included those posed by health care. London-based DeepMind, owned by Google’s parent company, Alphabet, focuses heavily on the specifics of using artificial intelligence in health... Read More »

Read More →

Chris Jackson/Getty Images A focus on artificial intelligence could lead to fewer people losing their sight. Tech industry insiders regularly herald AI as the solution to all of our problems, included those posed by health care. London-based DeepMind, owned by Google’s parent company, Alphabet, focuses heavily on the specifics of using artificial intelligence in health… Read More »

[...]

Read More

Researchers discover gene mutations linked with aggressive breast cancer

People at risk of a tough-to-treat, deadly form of breast cancer may now have a better chance of early diagnosis and protection against relapse. Researchers at the Mayo Clinic identified genetic mutations associated with triple-negative breast cancer, a type that generally requires extensive chemotherapy and and has lower five-year survival rates than other forms of... Read More »

Read More →

People at risk of a tough-to-treat, deadly form of breast cancer may now have a better chance of early diagnosis and protection against relapse. Researchers at the Mayo Clinic identified genetic mutations associated with triple-negative breast cancer, a type that generally requires extensive chemotherapy and and has lower five-year survival rates than other forms of… Read More »

[...]

Read More

FDA Grants Breakthrough Designation to Lenvima/Keytruda Combination

The FDA this week granted a third Breakthrough Therapy designation to lenvatinib (Lenvima), an oral kinase inhibitor used in combination with the anti-PD-1 therapy pembrolizumab (Keytruda). The most recent designation is for the treatment of patients with advanced and/or metastatic non-microsatellite instability high/proficient mismatch repair endometrial carcinoma (EC) who progressed following at least 1 prior... Read More »

Read More →

The FDA this week granted a third Breakthrough Therapy designation to lenvatinib (Lenvima), an oral kinase inhibitor used in combination with the anti-PD-1 therapy pembrolizumab (Keytruda). The most recent designation is for the treatment of patients with advanced and/or metastatic non-microsatellite instability high/proficient mismatch repair endometrial carcinoma (EC) who progressed following at least 1 prior… Read More »

[...]

Read More

FDA clears Sentimag System for lymph node detection in breast cancer

The FDA cleared the Magtrace and Sentimag Magnetic Localization System for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. The Magtrace and Sentimag Magnetic Localization System, also called Sentimag System, (Endomagnetics) uses magnetic detection during lymph biopsy to identify sentinel lymph nodes for surgical removal. “Sentinel lymph node biopsies are crucial for... Read More »

Read More →

The FDA cleared the Magtrace and Sentimag Magnetic Localization System for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. The Magtrace and Sentimag Magnetic Localization System, also called Sentimag System, (Endomagnetics) uses magnetic detection during lymph biopsy to identify sentinel lymph nodes for surgical removal. “Sentinel lymph node biopsies are crucial for… Read More »

[...]

Read More

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old

TUESDAY, July 24, 2018 — The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3 in JAMA Dermatology. A 97-year-old female patient had developed multiple cutaneous squamous cell carcinomas. On a... Read More »

Read More →

TUESDAY, July 24, 2018 — The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3 in JAMA Dermatology. A 97-year-old female patient had developed multiple cutaneous squamous cell carcinomas. On a… Read More »

[...]

Read More

FDA to Form Workgroup to Study Drug Importation Will focus only on off-patent drugs

WASHINGTON — Health and Human Services (HHS) Secretary Alex Azar on Thursday asked the FDA to develop a working group to consider whether importation of certain prescription drugs might help bring drug prices down. “We look forward to working with [FDA] Commissioner [Scott] Gottlieb and the FDA to explore how importation could help address price... Read More »

Read More →

WASHINGTON — Health and Human Services (HHS) Secretary Alex Azar on Thursday asked the FDA to develop a working group to consider whether importation of certain prescription drugs might help bring drug prices down. “We look forward to working with [FDA] Commissioner [Scott] Gottlieb and the FDA to explore how importation could help address price… Read More »

[...]

Read More

Three years after steep price hike, Martin Shkreli’s drug company is losing money, documents show

Martin Shkreli’s former company is losing money, watching sales of its famously costly medicine slip while considering yet another name change. Vyera Pharmaceuticals, formerly called Turing Pharmaceuticals, lost more than $1 million in the first quarter of 2018, according to financial documents obtained by STAT. Sales, driven by the $750-a-pill Daraprim, have been on the... Read More »

Read More →

Martin Shkreli’s former company is losing money, watching sales of its famously costly medicine slip while considering yet another name change. Vyera Pharmaceuticals, formerly called Turing Pharmaceuticals, lost more than $1 million in the first quarter of 2018, according to financial documents obtained by STAT. Sales, driven by the $750-a-pill Daraprim, have been on the… Read More »

[...]

Read More

Novel Scanner Technique Can Potentially Replace Mammograms for Breast Cancer Detection

A new laser-sonic scanner technique may help women avoid the discomfort of traditional mammography procedures by offering an alternative, more efficient way to screen for breast cancer, according to a recent study. Although mammograms are effective in detecting breast cancer and reducing deaths from the disease, many women avoid having their mammograms taken as often... Read More »

Read More →

A new laser-sonic scanner technique may help women avoid the discomfort of traditional mammography procedures by offering an alternative, more efficient way to screen for breast cancer, according to a recent study. Although mammograms are effective in detecting breast cancer and reducing deaths from the disease, many women avoid having their mammograms taken as often… Read More »

[...]

Read More

Page 1 of 28

Categories
Archives